Dr. Jean-Pierre Samadosi
CEO & Founder
Replay available
Atea Pharmaceuticals, Inc. (AVIR) Q1 2026 Earnings Call
Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) Q1 2026 earnings conference call, held 2026-05-12. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Janet Hammond
Chief Development Officer
Dr. Arantahorga
Chief Medical Officer
Andrea Corcoran
CFO & Executive Vice President, Legal
Maxwell Scorer
Analyst, Morgan Stanley
Jonathan Miller
Analyst, Evercore
Andy Shea
Analyst, William Blair
John Vavrica
Chief Commercial Officer
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Atea Pharmaceuticals, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:01.594 Ladies and gentlemen, thank you for standing by. 00:00:01.594 -- 00:00:06.723 Welcome to Attea Pharmaceuticals' first quarter 2026 earnings conference 00:00:06.723 -- 00:00:10.230 call. At this time, all participants are in a listen-only mode. 00:00:10.230 -- 00:00:13.556 A brief question and answer session will follow the formal presentation. 00:00:13.556 -- 00:00:17.122 If you should require operator assistance during the conference, please press star zero 00:00:17.122 -- 00:00:21.831 on your telephone keypad. I will now turn it over to the Attea management team. 00:00:21.831 -- 00:00:24.044 Please go ahead. 00:00:24.044 -- 00:00:29.011 Hi, thank you, Operator. Good afternoon, everyone, and welcome to Atea Pharmaceuticals' 00:00:29.011 -- 00:00:33.858 first quarter 2026 financial results and business update conference call. 00:00:33.858 -- 00:00:38.966 Earlier today, we issued a press release which outlines the topics we plan to discuss. 00:00:38.966 -- 00:00:42.931 You can access the press release as well as the slides that we'll be reviewing today 00:00:42.931 -- 00:00:47.876 by visiting the investor section of our website at ir.ateafarma.com. 00:00:48.159 -- 00:00:52.545 With me today from Atea are our Chief Executive Officer and Founder, Dr. 00:00:52.545 -- 00:00:55.916 Jean-Pierre Samadosi, Chief Development Officer, Dr. 00:00:55.916 -- 00:01:01.562 Janet Hammond, Chief Commercial Officer, John Vavrica, Chief Medical Officer, Dr. 00:01:01.562 -- 00:01:06.648 Arantahorga, and Chief Financial Officer and Executive Vice President of Legal, Andrea 00:01:06.648 -- 00:01:10.953 Corcoran, who will all be available for the Q&A portion of today's call. 00:01:10.953 -- 00:01:15.498 Before we begin the call, and as outlined on slide tw...